5 Reasons Big Biotech Could Gain 25%-30%

Leerink analyst Geoff Porges sees 25% or better upside ahead for Big Biotech. Here’s why
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>